STAT3 and hepatocellular carcinoma: As to explore whether STAT3 inhibition has a synthetic effect with the anti-PD-1 agent in the liver orthotopic HCC mice model, we used napabucasin (BBI608), a small molecule inhibitor of STAT3 phosphorylation.